0001728117-23-000052.txt : 20230509
0001728117-23-000052.hdr.sgml : 20230509
20230509161234
ACCESSION NUMBER: 0001728117-23-000052
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230505
FILED AS OF DATE: 20230509
DATE AS OF CHANGE: 20230509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hasnain Faheem
CENTRAL INDEX KEY: 0001352620
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38796
FILM NUMBER: 23902130
MAIL ADDRESS:
STREET 1: 14 CAMBRIDGE CENTER
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gossamer Bio, Inc.
CENTRAL INDEX KEY: 0001728117
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 475461709
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3013 SCIENCE PARK
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 922-0718
MAIL ADDRESS:
STREET 1: 3013 SCIENCE PARK
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wf-form4_168366312804581.xml
FORM 4
X0407
4
2023-05-05
0
0001728117
Gossamer Bio, Inc.
GOSS
0001352620
Hasnain Faheem
3013 SCIENCE PARK ROAD
SAN DIEGO
CA
92121
1
1
0
0
President & CEO
0
Stock Option (Right to Buy)
1.36
2023-05-05
4
A
0
750000
0
A
2033-05-04
Common Stock
750000.0
750000
D
The Option shall vest and become exercisable as follows: (i) with respect to 50% of the shares subject to the option, the Issuer's common stock achieving a 30-day average stock price at or above $5 per share within four years of the grant date; (ii) with respect to 25% of the shares subject to the option, the Issuer's common stock achieving a 30-day average stock price at or above $7.50 per share within four years of the grant date; and (iii) with respect to the remaining 25% of the shares subject to the option, the Issuer's common stock achieving a 30-day average stock price at or above $10 per share within four years of the grant date; in each case subject to the Reporting Person's continuous service to the Issuer on each such vesting date; provided in no event will any portion of the option vest prior to the first anniversary of the grant date.
/s/ Jeff Boerneke, Attorney-in-Fact
2023-05-09